# Galvus (Vildagliptin) vs Placebo in Combination With Metformin and Insulin

> **NCT01757587** · PHASE4 · COMPLETED · sponsor: **Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète** · enrollment: 39 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Vildagliptin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01757587
- **Lead sponsor:** Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2015-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01757587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01757587, "Galvus (Vildagliptin) vs Placebo in Combination With Metformin and Insulin". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01757587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*